
Progress
0%
Cardiovascular
CA-125
Malignancies
Endometrial, ovarian, bowel, breast cancers
Benign Conditions
Liver cirrhosis
Ovarian cysts
Pelvic inflammatory disease (PID)
Uterine fibroids
Pregnancy
Endometriosis
Adenomyosis
Peritoneal irritation
Key Considerations
Limited specificity → Elevated in both malignant & benign conditions
Benign causes often due to peritoneal irritation/inflammation
CA-125
Definition
A glycoprotein tumour marker produced by coelomic epithelium and its derivatives
Primarily used to support diagnosis and monitor treatment response in ovarian cancer
Causes of Elevated CA-125
Malignancies
Ovarian, endometrial, breast and bowel cancers
Benign Conditions
Liver cirrhosis with ascites
Ovarian cysts
Pelvic inflammatory disease
Uterine fibroids
Endometriosis and adenomyosis
Pregnancy, particularly in the first trimester
Peritoneal irritation from infections or inflammatory processes
Normal Variants
Mild elevations may occur during menstruation without underlying pathology
Clinical Utility and Limitations
Limited specificity, as levels are elevated in both malignant and benign conditions
Not recommended for screening in asymptomatic women
Serial measurements are more useful than a single value in monitoring treatment response or detecting recurrence
Variability due to menstrual cycle and pregnancy necessitates clinical correlation
Investigations and Interpretation
Serum assay with normal levels typically <35 U/mL
Should be interpreted alongside clinical history, examination and imaging
Elevated levels in the presence of a pelvic mass increase suspicion for ovarian malignancy
Serial measurements guide management decisions in known ovarian cancer
Monitoring and Follow-Up
Regular monitoring is essential in ovarian cancer to assess treatment efficacy and detect relapse
In benign conditions, CA-125 levels usually normalise with resolution of inflammation
Changes in CA-125 must be correlated with clinical and imaging findings
Notes:
CA-125 is most valuable in the first 6 weeks of pregnancy for confirming intrauterine pregnancy
In liver cirrhosis, elevated CA-125 is typically secondary to peritoneal irritation from ascites
Combining CA-125 with other markers and imaging enhances diagnostic accuracy for pelvic masses
CA-125 should be used as part of a comprehensive evaluation rather than in isolation
Awareness of assay variability and influencing factors, such as hormonal fluctuations, is important in interpretation
Bookmark Failed!
Bookmark Saved!